Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2015, Article ID 419561, 6 pages
http://dx.doi.org/10.1155/2015/419561
Research Article

Evaluation of the Selenotranscriptome Expression in Two Hepatocellular Carcinoma Cell Lines

1Dipartimento di Biochimica, Biofisica e Patologia Generale, Seconda Università degli Studi di Napoli, 80138 Napoli, Italy
2Dipartimento di Medicina Sperimentale, Seconda Università degli Studi di Napoli, 80138 Napoli, Italy
3Servizio di Informatica Medica, Azienda Ospedaliera Universitaria, Seconda Università di Napoli, 80138 Napoli, Italy
4CROM, Istituto Nazionale Tumori “Fondazione G. Pascale”, IRCCS, 80131 Napoli, Italy

Received 2 April 2015; Accepted 9 June 2015

Academic Editor: José A. Sánchez-Alcázar

Copyright © 2015 Stefano Guariniello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. B. El-Serag and K. L. Rudolph, “Hepatocellular carcinoma: epidemiology and molecular carcinogenesis,” Gastroenterology, vol. 132, no. 7, pp. 2557–2576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, “Cancer statistics, 2007,” CA: A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Castello, S. Scala, G. Palmieri, S. A. Curley, and F. Izzo, “HCV-related hepatocellular carcinoma: from chronic inflammation to cancer,” Clinical Immunology, vol. 134, no. 3, pp. 237–250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Costantini, F. Capone, E. Guerriero et al., “Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection,” PLoS ONE, vol. 7, no. 6, Article ID e39486, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Bruix and J. M. Llovet, “Prognostic prediction and treatment strategy in hepatocellular carcinoma,” Hepatology, vol. 35, no. 3, pp. 519–524, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma,” Hepatology, vol. 42, no. 5, pp. 1208–1236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Costantini, G. Di Bernardo, M. Cammarota, G. Castello, and G. Colonna, “Gene expression signature of human HepG2 cell line,” Gene, vol. 518, no. 2, pp. 335–345, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G. V. Kryukov, S. Castellano, S. V. Novoselov et al., “Characterization of mammalian selenoproteomes,” Science, vol. 300, no. 5624, pp. 1439–1443, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. F. P. Bellinger, A. V. Raman, M. A. Reeves, and M. J. Berry, “Regulation and function of selenoproteins in human disease,” Biochemical Journal, vol. 422, no. 1, pp. 11–22, 2009. View at Google Scholar · View at Scopus
  11. R. Raucci, G. Colonna, E. Guerriero et al., “Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma,” Biochimica et Biophysica Acta, vol. 1814, no. 4, pp. 513–522, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Di Stasio, M. G. Volpe, G. Colonna et al., “A possible predictive marker of progression for hepatocellular carcinoma,” Oncology Letters, vol. 2, no. 6, pp. 1247–1251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Guerriero, M. Accardo, F. Capone, G. Colonna, G. Castello, and S. Costantini, “Assessment of the Selenoprotein M (SELM) over-expression on human hepatocellular carcinoma tissues by immunohistochemistry,” European Journal of Histochemistry, vol. 58, no. 4, 2014. View at Publisher · View at Google Scholar
  14. G. di Bernardo, N. Alessio, C. Dell'Aversana et al., “Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells,” Journal of Cellular Physiology, vol. 225, no. 2, pp. 537–544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J.-L. Hsieh, C.-L. Wu, C.-H. Lee, and A.-L. Shiau, “Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function,” Clinical Cancer Research, vol. 9, no. 1, pp. 338–345, 2003. View at Google Scholar · View at Scopus
  16. S. P. Hussain, J. Schwank, F. Staib, X. W. Wang, and C. C. Harris, “TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer,” Oncogene, vol. 26, no. 15, pp. 2166–2176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. F. Brito, A. M. Abrantes, C. Pinto-Costa et al., “Hepatocellular carcinoma and chemotherapy: the role of p53,” Chemotherapy, vol. 58, no. 5, pp. 381–386, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. W. C. Hawkes and Z. Alkan, “Regulation of redox signaling by selenoproteins,” Biological Trace Element Research, vol. 134, no. 3, pp. 235–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. R. Copeland, J. E. Fletcher, B. A. Carlson, D. L. Hatfield, and D. M. Driscoll, “A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs,” The EMBO Journal, vol. 19, no. 2, pp. 306–314, 2000. View at Google Scholar
  20. W. Du, R. Rani, J. Sipple et al., “The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters,” Blood, vol. 119, no. 18, pp. 4142–4151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. L. Bloomfield, S. A. Osborne, D. D. Kennedy, F. M. Clarke, and K. F. Tonissen, “Thioredoxin-mediated redox control of the transcription factor Sp1 and regulation of the thioredoxin gene promoter,” Gene, vol. 319, no. 1-2, pp. 107–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Guichard, G. Amaddeo, S. Imbeaud et al., “Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma,” Nature Genetics, vol. 44, no. 6, pp. 694–698, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Tomimaru, H. Eguchi, H. Wada et al., “Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells,” British Journal of Cancer, vol. 102, no. 10, pp. 1483–1490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. P. Medina, O. A. Romero, T. Kohno et al., “Frequent BRG1/SMARCA4–inactivating mutations in human lung cancer cell lines,” Human Mutation, vol. 29, no. 5, pp. 617–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Hirano, H. Tanaka, Y. Hirano et al., “Functional interference of SP1 and NF-κB through the same DNA binding site,” Molecular and Cellular Biology, vol. 18, no. 3, pp. 1266–1274, 1998. View at Google Scholar · View at Scopus
  26. J.-Y. Chuang, C.-H. Wu, M.-D. Lai, W.-C. Chang, and J.-J. Hung, “Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells,” International Journal of Cancer, vol. 125, no. 9, pp. 2066–2076, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Sande and M. L. Privalsky, “Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors,” Molecular Endocrinology, vol. 10, no. 7, pp. 813–825, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. H.-K. Choi, K.-C. Choi, H.-B. Kang et al., “Function of multiple lis-homology domain/WD-40 repeat-containing proteins in feed-forward transcriptional repression by silencing mediator for retinoic and thyroid receptor/nuclear receptor corepressor complexes,” Molecular Endocrinology, vol. 22, no. 5, pp. 1093–1104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Curcio-Morelli, A. M. Zavacki, M. Christofollete et al., “Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation,” The Journal of Clinical Investigation, vol. 112, no. 2, pp. 189–196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. L. A. T. Arnaldi, R. C. Borra, R. M. B. Maciel, and J. M. Cerutti, “Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors,” Thyroid, vol. 15, no. 3, pp. 210–221, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Sabatino, G. Iervasi, P. Ferrazzi, D. Francesconi, and I. J. Chopra, “A study of iodothyronine 5′-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues,” Life Sciences, vol. 68, no. 2, pp. 191–202, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. H. C. Chi, C.-Y. Chen, M.-M. Tsai, C.-Y. Tsai, and K.-H. Lin, “Molecular functions of thyroid hormones and their clinical significance in liver-related diseases,” BioMed Research International, vol. 2013, Article ID 601361, 16 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus